Results 71 to 80 of about 61,964 (279)

Treatment Algorithms for Systemic Sclerosis According to Experts

, 2018
OBJECTIVE: There is a lack of agreement regarding treatment for many aspects of systemic sclerosis (SSc). We undertook this study to generate SSc treatment algorithms endorsed by a high percentage of SSc experts.
Walker KM, Pope JE, 1. Fernández-Codina A, Murdaca G, Scleroderma Algorithm Group   +4 more
core   +2 more sources

A review of recent studies on the pathogenesis of Systemic Sclerosis: focus on fibrosis pathways

Frontiers in Immunology
Systemic Sclerosis (SSc) is a systemic autoimmune disease of unknown etiology characterized by the development of frequently progressive cutaneous and internal organ fibrosis accompanied by severe vascular alterations.
Sergio A. Jimenez, Fabian A. Mendoza, Fabian A. Mendoza, Sonsoles Piera-Velazquez   +3 more
doaj   +1 more source

Towards developing criteria for scleroderma renal crisis: A scoping review [PDF]

, 2017
OBJECTIVE: The absence of a gold standard for scleroderma renal crisis (SRC) has hindered our understanding of this problem. The objective of this scoping review was to identify the criteria used to define SRC in order to guide the development of a ...
Hoa, S, Denton, CP, Scleroderma Clinical Trials Consortium Scleroderma Renal Crisis, Stern, EP, Hudson, M, Investigators of the Scleroderma Clinical Trials Consortium Scle   +5 more
core  

Histological Changes of Linear Scleroderma “en Coup de Sabre”

, 2014
Introduction. Scleroderma is a chronic disease of unknown aetiology characterized by skin fibrosis and is divided into two clinical entities: localized scleroderma and systemic sclerosis.
Tophuria D., Matoshvili M., Katsitadze A., Kiladze N.   +3 more
core   +1 more source

Facial Cosmetic Therapy Use Among Patients With Systemic Sclerosis: An Australian Cohort Study

Arthritis Care &Research, EarlyView.
Objective Systemic sclerosis (SSc) is associated with numerous facial manifestations for which patients may engage in cosmetic therapies. It is unclear how patients with SSc use these therapies. This study sought to characterize patient engagement and experiences with cosmetic therapies for SSc‐related and non‐SSc–related facial changes.
Zachary Warren, Diane Apostolopoulos, Gene‐Siew Ngian, Amanda M. Saracino, Laura Ross, Nava Ferdowsi, Jennifer Walker, Cindy Hall, Kim Griggs, Susanna Proudman, Wendy Stevens, Joanne Sahhar   +11 more
wiley   +1 more source

Microvascular Damage Is Associated With Carotid Wall Structural Changes in Systemic Sclerosis: A Capillaroscopy and Ultrasound‐Based Observational Study

Arthritis Care &Research, EarlyView.
Objective Systemic sclerosis (SSc) is characterized by cardiovascular risk excess not fully explained by traditional factors. Whether the severity of microvascular damage correlates with structural subclinical atherosclerosis remains unclear. We investigated the relationship between nailfold videocapillaroscopy (NVC) abnormalities and carotid ...
Eugenio Capparelli, Luca Clerici, Francesco Lapia, Giusy C. Moltisanti, Eleonora Zaccara, Greta Pellegrino, Daniela Bompane, Francesca Capelli, Letizia Ferrami, Laura Castelnovo, Antonio Tamburello, Maria Sole Chimenti, Paola Faggioli, Antonino Mazzone   +13 more
wiley   +1 more source

Generative AI Utilization and Perspectives Among Reproductive‐Age Women with Systemic Autoimmune and Rheumatic Diseases

Arthritis Care &Research, Accepted Article.
Objective Reproductive‐age women with systemic autoimmune and rheumatic diseases (SARDs) have unique information needs related to their SARDs and reproductive health. We sought to understand their use of and receptivity to current and hypothetical generative artificial intelligence (AI) tools for health information‐seeking. Methods We conducted a cross‐
Mariam Arif, Catherine Wright, Samantha Rodriguez, Sarah Graves, Tamar Krishnamurti, Mehret Birru Talabi   +5 more
wiley   +1 more source

Frequency of occurrenceof tumor-associated localized scleroderma

Лечащий Врач
Background. Tumor-associated localized scleroderma is observed among patients with localized scleroderma. It is assumed that the development of this condition may be facilitated by both the inflammatory processes in scleroderma and oncological processes ...
P. O. Kazakova
doaj   +1 more source

Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease [PDF]

, 2019
Although several genetic associations with scleroderma (SSc) are defined, very little is known on genetic susceptibility to SSc-associated interstitial lung disease (SSc-ILD).
Maher, Toby M, Margaritopoulos, George, Kokosi, M., George, Peter M, Wells, A.U., Daccord, Cecile, Nihtyanova, Svetlana, Visca, Dina, Molyneaux, Philip L, Kouranos, Vasilis, Renzoni, E.A., Denton, Christopher P, Daccord, C., Molyneaux, P.L., Nihtyanova, S., Ong, V., Wells, Athol U, Wain, L.V., Visca, D., De Lauretis, Angelo, Denton, C.P., Chua, F., Wain, Louise V, Abraham, David J, Renzoni, Elisabetta A, Stock, CJW, Abraham, D.J., Margaritopoulos, G., Kokosi, Maria, George, P.M., Stock, Carmel JW, Kouranos, V., De Lauretis, A., Ong, Voon, Maher, T.M., Chua, Felix   +35 more
core   +1 more source

Silicone Breast Implants as a Model System for Understanding Polymer Permeation in Soft Materials In Vivo

Advanced Healthcare Materials, EarlyView.
Silicone breast implants are presented as a model system for understanding polymer permeation in vivo. Rather than representing material failure, “gel bleed” emerges from solution–diffusion transport‐mediated. By integrating polymer architecture, physicochemical transport, and biointerfacial processes, this review provides a unified framework that ...
D. Bouyer, H. Mutlu, C. Charmette, E. Randrianaridera, Z. Adaidi, R. Hedna, L. Pieuchot, I. Pluvy, K. Anselme, N. Couturier, J. P. Mericq, A. Ponche, I. Brigaud   +12 more
wiley   +1 more source